NasdaqCM - Delayed Quote • USD
Moleculin Biotech, Inc. (MBRX)
At close: April 23 at 4:00 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-24,101.0000
-24,101.0000
-27,639.0000
-18,951.0000
-17,771.0000
Investing Cash Flow
-124.0000
-124.0000
-67.0000
-19.0000
-374.0000
Financing Cash Flow
4,651.0000
4,651.0000
-23.0000
74,724.0000
22,549.0000
End Cash Position
23,550.0000
23,550.0000
43,145.0000
70,903.0000
15,173.0000
Income Tax Paid Supplemental Data
--
--
--
15.0000
24.0000
Capital Expenditure
-124.0000
-124.0000
-67.0000
-19.0000
-376.0000
Issuance of Capital Stock
4,166.0000
4,166.0000
--
74,684.0000
22,561.0000
Free Cash Flow
-24,225.0000
-24,225.0000
-27,706.0000
-18,970.0000
-18,147.0000
12/31/2020 - 6/2/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PHRRF PharmaTher Holdings Ltd.
0.1666
+4.35%
PHRM.CN PharmaTher Holdings Ltd.
0.2250
+4.65%
SNGX Soligenix, Inc.
0.4000
-1.43%
NRBO NeuroBo Pharmaceuticals, Inc.
3.0200
-3.21%
PULM Pulmatrix, Inc.
2.0201
+0.50%
RNAC Cartesian Therapeutics, Inc.
20.59
+12.76%
TENX Tenax Therapeutics, Inc.
3.5000
-1.41%
TCON TRACON Pharmaceuticals, Inc.
1.8500
+1.65%
UNCY Unicycive Therapeutics, Inc.
1.0700
-6.96%
CNSP CNS Pharmaceuticals, Inc.
0.2100
+7.14%